Concepts (82)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Bradycardia | 1 | 2021 | 292 | 0.68 | Why? |
| Heart Rate | 1 | 2021 | 1527 | 0.46 | Why? |
| Vitamin K | 4 | 2019 | 263 | 0.38 | Why? |
| Atrial Fibrillation | 5 | 2020 | 2320 | 0.34 | Why? |
| Adenosine Monophosphate | 1 | 2021 | 5652 | 0.26 | Why? |
| Alanine | 1 | 2021 | 5687 | 0.26 | Why? |
| Tachycardia, Supraventricular | 1 | 2020 | 52 | 0.21 | Why? |
| Cardiac Pacing, Artificial | 1 | 2021 | 160 | 0.20 | Why? |
| Fibrinolytic Agents | 2 | 2020 | 1702 | 0.17 | Why? |
| Tachycardia, Ventricular | 1 | 2020 | 251 | 0.17 | Why? |
| Ventricular Dysfunction, Right | 2 | 2021 | 639 | 0.16 | Why? |
| Dabigatran | 1 | 2019 | 204 | 0.16 | Why? |
| Cardiology Service, Hospital | 1 | 2021 | 602 | 0.14 | Why? |
| Dyslipidemias | 1 | 2021 | 791 | 0.14 | Why? |
| Thiazoles | 1 | 2019 | 496 | 0.14 | Why? |
| Factor Xa Inhibitors | 1 | 2019 | 490 | 0.13 | Why? |
| Pyridines | 1 | 2019 | 680 | 0.12 | Why? |
| Ventricular Dysfunction, Left | 1 | 2021 | 993 | 0.12 | Why? |
| Heart Valve Prosthesis | 1 | 2018 | 533 | 0.11 | Why? |
| Heart Valve Prosthesis Implantation | 1 | 2018 | 552 | 0.11 | Why? |
| Italy | 8 | 2021 | 38444 | 0.11 | Why? |
| Arrhythmias, Cardiac | 2 | 2021 | 2510 | 0.11 | Why? |
| Hospital Mortality | 4 | 2021 | 22087 | 0.10 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 1510 | 0.10 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.09 | Why? |
| Anticoagulants | 2 | 2018 | 9563 | 0.08 | Why? |
| Risk Assessment | 4 | 2021 | 25439 | 0.07 | Why? |
| Hospitalization | 5 | 2021 | 54280 | 0.07 | Why? |
| Aged | 12 | 2021 | 215776 | 0.06 | Why? |
| Databases, Factual | 1 | 2017 | 6248 | 0.06 | Why? |
| Incidence | 2 | 2021 | 25622 | 0.06 | Why? |
| Risk Factors | 5 | 2021 | 71621 | 0.06 | Why? |
| Pulmonary Embolism | 1 | 2020 | 4775 | 0.05 | Why? |
| Propensity Score | 2 | 2019 | 2690 | 0.05 | Why? |
| Aged, 80 and over | 8 | 2021 | 88759 | 0.05 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.05 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.05 | Why? |
| Male | 12 | 2021 | 367725 | 0.05 | Why? |
| Female | 12 | 2021 | 380317 | 0.04 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.04 | Why? |
| Retrospective Studies | 7 | 2021 | 105322 | 0.04 | Why? |
| Hemorrhage | 2 | 2019 | 3013 | 0.04 | Why? |
| Thromboembolism | 2 | 2019 | 2101 | 0.04 | Why? |
| International Normalized Ratio | 1 | 2018 | 300 | 0.04 | Why? |
| Cardiovascular Diseases | 1 | 2020 | 11497 | 0.04 | Why? |
| Ischemic Attack, Transient | 1 | 2019 | 439 | 0.04 | Why? |
| Probability | 1 | 2019 | 923 | 0.04 | Why? |
| Drug Administration Schedule | 1 | 2020 | 2324 | 0.03 | Why? |
| Prognosis | 3 | 2021 | 32490 | 0.03 | Why? |
| Organizational Innovation | 1 | 2021 | 2468 | 0.03 | Why? |
| Hypertension, Pulmonary | 1 | 2020 | 970 | 0.03 | Why? |
| Stroke Volume | 1 | 2021 | 2153 | 0.03 | Why? |
| Humans | 12 | 2021 | 930598 | 0.03 | Why? |
| Recurrence | 1 | 2020 | 3675 | 0.03 | Why? |
| Administration, Oral | 1 | 2018 | 2340 | 0.03 | Why? |
| Multivariate Analysis | 1 | 2020 | 5440 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2019 | 4260 | 0.02 | Why? |
| Medication Adherence | 1 | 2019 | 1270 | 0.02 | Why? |
| Registries | 2 | 2020 | 12327 | 0.02 | Why? |
| Follow-Up Studies | 2 | 2018 | 17020 | 0.02 | Why? |
| Neoplasms | 1 | 2017 | 17251 | 0.02 | Why? |
| Echocardiography | 1 | 2021 | 3661 | 0.02 | Why? |
| Pilot Projects | 1 | 2019 | 5182 | 0.02 | Why? |
| Renal Insufficiency, Chronic | 1 | 2020 | 2654 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2019 | 7268 | 0.02 | Why? |
| Patient Admission | 1 | 2020 | 5250 | 0.02 | Why? |
| Disease Progression | 1 | 2021 | 13580 | 0.01 | Why? |
| Treatment Outcome | 2 | 2019 | 51732 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2020 | 8207 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Stroke | 1 | 2019 | 8839 | 0.01 | Why? |
| Cohort Studies | 1 | 2019 | 36005 | 0.01 | Why? |
| Infection Control | 1 | 2021 | 23131 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
| Adult | 1 | 2020 | 244371 | 0.00 | Why? |
| Pandemics | 1 | 2020 | 389249 | 0.00 | Why? |
Attena's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(82)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(90)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_